Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.

View/ Open
Date
2014-08ICR Author
Author
Tubio, JMC
Li, Y
Ju, YS
Martincorena, I
Cooke, SL
Tojo, M
Gundem, G
Pipinikas, CP
Zamora, J
Raine, K
Menzies, A
Roman-Garcia, P
Fullam, A
Gerstung, M
Shlien, A
Tarpey, PS
Papaemmanuil, E
Knappskog, S
Van Loo, P
Ramakrishna, M
Davies, HR
Marshall, J
Wedge, DC
Teague, JW
Butler, AP
Nik-Zainal, S
Alexandrov, L
Behjati, S
Yates, LR
Bolli, N
Mudie, L
Hardy, C
Martin, S
McLaren, S
O'Meara, S
Anderson, E
Maddison, M
Gamble, S
Foster, C
Warren, AY
Whitaker, H
Brewer, D
Eeles, R
Cooper, C
Neal, D
Lynch, AG
Visakorpi, T
Isaacs, WB
Veer, LV
Caldas, C
Desmedt, C
Sotiriou, C
Aparicio, S
Foekens, JA
Eyfjörd, JE
Lakhani, SR
Thomas, G
Myklebost, O
Span, PN
Børresen-Dale, A-L
Richardson, AL
Van de Vijver, M
Vincent-Salomon, A
Van den Eynden, GG
Flanagan, AM
Futreal, PA
Janes, SM
Bova, GS
Stratton, MR
McDermott, U
Campbell, PJ
ICGC Breast Cancer Group
ICGC Bone Cancer Group
ICGC Prostate Cancer Group
Type
Journal Article
Metadata
Show full item recordAbstract
Long interspersed nuclear element-1 (L1) retrotransposons are mobile repetitive elements that are abundant in the human genome. L1 elements propagate through RNA intermediates. In the germ line, neighboring, nonrepetitive sequences are occasionally mobilized by the L1 machinery, a process called 3' transduction. Because 3' transductions are potentially mutagenic, we explored the extent to which they occur somatically during tumorigenesis. Studying cancer genomes from 244 patients, we found that tumors from 53% of the patients had somatic retrotranspositions, of which 24% were 3' transductions. Fingerprinting of donor L1s revealed that a handful of source L1 elements in a tumor can spawn from tens to hundreds of 3' transductions, which can themselves seed further retrotranspositions. The activity of individual L1 elements fluctuated during tumor evolution and correlated with L1 promoter hypomethylation. The 3' transductions disseminated genes, exons, and regulatory elements to new locations, most often to heterochromatic regions of the genome.
Collections
Subject
ICGC Breast Cancer Group
ICGC Bone Cancer Group
ICGC Prostate Cancer Group
Chromatin
Humans
Neoplasms
Translocation, Genetic
DNA Transposable Elements
Transduction, Genetic
Mutagenesis, Insertional
Long Interspersed Nucleotide Elements
Genome, Human
Exons
Carcinogenesis
Research team
Oncogenetics
Language
eng
License start date
2014-08
Citation
Science (New York, N.Y.), 2014, 345 (6196), pp. 1251343 - ?
Related items
Showing items related by title, author, creator and subject.
-
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Lawrenson, K; Kar, S; McCue, K; Kuchenbaeker, K; Michailidou, K; et al. (2016-09-07)A locus at 19p13 is associated with breast cancer (BC) and ovarian cancer (OC) risk. Here we analyse 438 SNPs in this region in 46,451 BC and 15,438 OC cases, 15,252 BRCA1 mutation carriers and 73,444 controls and identify ... -
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer.
Painter, JN; O'Mara, TA; Marquart, L; Webb, PM; Attia, J; et al. (2016-11)Background The strongest known risk factor for endometrial cancer is obesity. To determine whether SNPs associated with increased body mass index (BMI) or waist-hip ratio (WHR) are associated with endometrial cancer risk, ... -
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
Easton, DF; Lesueur, F; Decker, B; Michailidou, K; Li, J; et al. (2016-05)Background BRCA1 interacting protein C-terminal helicase 1 (BRIP1) is one of the Fanconi Anaemia Complementation (FANC) group family of DNA repair proteins. Biallelic mutations in BRIP1 are responsible for FANC group J, ...